Evid Invest
Who owns OBXWhat OBX owns — n/a

Who owns Obsidian Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of OBX from SEC Form 13F filings across 60 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 60 institutions disclosed 50.6M shares of Obsidian Therapeutics, Inc. worth $695.4M — about 123.4% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.

60

13F holders

$695.4M

value, 2026 filers

123.4%

of shares outstanding (50.6M sh)

60

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of OBX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1RA CAPITAL MANAGEMENT, L.P.NEW6.0M$81.8M0.8%14.5%new
2Atlas Venture Life Science Advisors, LLCNEW4.5M$61.8M9.8%11%new
3Paradigm Biocapital Advisors LPNEW4.2M$57.1M1.1%10.1%new
4NOVO HOLDINGS A/SNEW3.1M$42.9M2.9%7.6%new
5Trails Edge Capital Partners, LPNEW2.5M$34.3M4.9%6.1%new
6VANGUARD CAPITAL MANAGEMENT LLCNEW2.4M$33.5M0.0%6%new
7Octagon Capital Advisors LPNEW2.4M$33.2M4.4%5.9%new
8TCG Crossover Management, LLCNEW2.2M$30.2M0.9%5.4%new
9Deep Track Capital, LPNEW2.1M$29.1M0.5%5.2%new
10CITADEL ADVISORS LLCNEW1.9M$26.7M0.0%4.7%new
11Blue Owl Capital Holdings LPNEW1.5M$20.4M3.7%3.6%new
12Spruce Street Capital LPNEW1.2M$17.2M2.7%3%new
13Alphabet Inc.NEW1.2M$16.8M0.0%3%new
14Nantahala Capital Management, LLCNEW1.2M$16.5M0.5%2.9%new
15PRICE T ROWE ASSOCIATES INC /MD/NEW1.1M$14.5M0.0%2.6%new
16Nan Fung Group Holdings LtdNEW918,765$12.6M8.4%2.2%new
17Foresite Capital Management VI LLCNEW916,063$12.6M2.2%2.2%new
18Caligan Partners LPNEW886,281$12.2M0.7%2.2%new
19Pivotal bioVenture Partners Investment Advisor LLCNEW860,343$11.8M4.7%2.1%new
20SAMSARA BIOCAPITAL, LLCNEW837,173$11.5M1.1%2%new
21Redmile Group, LLCNEW833,157$11.4M0.8%2%new
22BlackRock, Inc.NEW775,759$10.7M0.0%1.9%new
23Janus Henderson Group Ltd.NEW728,700$10.0M0.0%1.8%new
24EVENTIDE ASSET MANAGEMENT, LLCNEW624,972$9.1M0.1%1.5%new
25Balyasny Asset Management L.P.NEW587,724$7.8M0.0%1.4%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.